by SWK Holdings | Feb 21, 2019 | archive, Case Study
Narcan is the only FDA approved, intranasal Naloxone product for the treatment of opioid overdose Narcan is appropriately priced with revenue growth due to a differentiated nasal dosing and expanded distribution, not price hikes Opiant is a publicly traded drug...
by SWK Holdings | Feb 21, 2019 | archive, Case Study
Orametrix was a Dallas-based, digital orthodontic company providing robotically bent and highly-accurate wire arches for braces In late 2016 the company approached SWK in need of funding to expand into the clear aligner market Upon completion of this project,...
by SWK Holdings | Jan 2, 2019 | Home-Slider
We See Value That Others Cannot. Bespoke capital solutions for commercial-stage healthcare and life science companies and royalty owners Partner With...
